Status:
WITHDRAWN
Capsaicin in Treatment of Rhinogenic Headache
Lead Sponsor:
University of Nebraska
Conditions:
Headache Disorders
Eligibility:
All Genders
19-100 years
Phase:
NA
Brief Summary
Description: Capsaicin (8- methyl-N-vanillyl-6-nonenamide) has been demonstrated to have a therapeutic effect in idiopathic rhinitis. We hypothesize that capsaicin has a therapeutic effect on rhinogen...
Detailed Description
1. Title: The role of capsaicin in treatment of rhinogenic headache 2. Description: Capsaicin (8- methyl-N-vanillyl-6-nonenamide) has been demonstrated to have a therapeutic effect in idiopathic rhini...
Eligibility Criteria
Inclusion
- Consenting Adults aged 19-100 presenting to the Otolaryngology DepartmentofUniversityof Nebraska Medical center complaining of headaches/ facial pain and pressure Diagnosis of a primary rhinogenic headache disorder by the senior authors.
Exclusion
- Exclusion criteria include: pregnancy, age less than 19, active history of smoking, presence of confirmed sinonasal disease, fibromyalgia, poorly controlled chronic health problems, allergies to chili peppers or any ingredient in the nasal spray, or confirmed Temporal Mandibular Joint (TMJ) arthralgia as the etiology of primary headache.
Key Trial Info
Start Date :
June 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 23 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03330639
Start Date
June 23 2020
End Date
June 23 2020
Last Update
September 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.